Understanding and influencing stakeholders

Evaluate if your leadership energizes or exhausts teams with a practical disruption checklist focused on curiosity, psychological safety, and growth.

CEOs face greater scrutiny than ever. IMD’s Jean-François Manzoni explains how CEOs should talk with trust and integrity.

The case places participants in the role of Helge Lund, chair of BP, on 4 October 2023. Only weeks earlier, BP's chief executive officer Bernard Looney had resigned over undisclosed relationships with colleagues. Looney had been the principal architect and public face of BP's 2020 strategy to transform BP from an international oil company into an "integrated energy company" aligned with a net-zero ambition by 2050. On the same day, activist investor Bluebell Capital Partners wrote to BP arguing that the strategy was "irrational" and had materially depressed the company's valuation. The challenge came amid conflicting signals: Shareholders had overwhelmingly backed BP's net-zero direction in 2022, but its share price had lagged key peers, raising questions about the economics, timing and execution of the transition. The case presents a board-level dilemma: How should Lund lead the board now, what strategic direction should it support and what CEO mandate should follow? Should BP defend the 2020 strategy, recalibrate it or pursue a more fundamental reset? The case concerns strategic governance and board oversight of transformation under pressure, rather than sustainability alone. It asks how boards should engage in strategy, interpret shifting stakeholder signals, assess investor fit and build support for a strategic pivot, and test organizational readiness for transformation. BP's 2020 strategy was bold and adapted to real external pressures, including climate policy, investor expectations and changing assumptions about the future of oil and gas. It also placed major demands on capital allocation, organizational capability, competitive advantage, stakeholder credibility and investor patience. By autumn 2023, the board had to ask not only whether the strategy remained directionally appropriate, but whether it had been sufficiently owned, explained, sequenced and governed.

Senior leaders rarely get their most important work done by issuing orders. A CTO cannot compel a partner firm, a dean cannot order a faculty to embrace a curriculum, a ministry cannot be forced to share data. On the questions that matter, outcome...

Part 2: Team doubts - learn diagnostics to pinpoint sources, build trust, and enlist supporters for stronger, shared leadership.

Discover how negative capability and reflective inaction can help leaders stay calm, listen deeply, and guide change with clarity.

The case chronicles the acute leadership crisis that erupted during the final minutes of the 2025 Africa Cup of Nations final match. It presents a real-world dilemma in which formal authority clashes with informal influence, and deeply held values...

In the years before its dramatic rise on the back of GLP-1 therapies, Novo Nordisk was best known for disciplined execution, a strong focus on diabetes and a long record of home-grown innovation. It met its targets with near predictable consistency, supported by stable structures and deeply embedded ways of working. Yet technological change, scientific uncertainty and increasing market pressures challenged whether a model built on reliability and internal self-sufficiency could keep pace. This case examines how Marcus Schindler, an externally hired leader who would later become the company's Chief Scientific Officer, attempted to future-proof Novo Nordisk's research and development organization. Rather than relying on incremental improvements, he introduced ambitious aspirations, pushed teams to experiment beyond their comfort zones, normalized failure as a source of learning and tested new organizational structures alongside the existing core. As students follow these choices, the case exposes a set of concrete leadership dilemmas: How fast should a leader push change in a stable, successful organization? How do you gain credibility as an outsider without full consensus? How do you balance accountability and psychological safety? And how do you allocate attention between short-term execution and long-term renewal? The dilemma becomes sharper as Novo Nordisk's GLP-1 therapies deliver extraordinary commercial success, shifting focus toward operational execution and raising questions about whether exploration risks being crowded out by exploitation. A deeper leadership question also emerges: How does a leader stay true to a long-term vision when runaway success pulls attention toward the here and now? This case challenges readers to think critically about leading change in high-performing organizations, driving transformational innovation, managing competing time horizons, and making leadership choices when success itself becomes the biggest constraint.

In 2022, Novo Nordisk was transitioning from its longstanding focus on diabetes treatments to multiple therapeutic areas while navigating other important challenges: • Changing market, competitive and regulatory environments • Dramatic growth due ...

Daniela Studer, a highly accomplished executive with a background in engineering and global leadership, now serves as the only woman on the board of Flosser, a niche construction materials company recently acquired by a larger public firm. Despite her expertise and a mandate to professionalize the board, Daniela finds herself struggling to influence the top management team. Dysfunctional dynamics that range from a lack of trust in the CTO to an exclusive relationship between the CEO and CFO threaten Flosser's performance and culture. Daniela's attempts to address these issues are met with resistance; her direct style, celebrated in her previous executive roles, is now seen as abrasive, and she is advised to be "gentler" in her board interactions. This case invites readers to reflect on the challenges of transitioning from an executive to a non-executive director role, a situation in which authority is more about influence than direct control. Daniela's dilemma – whether to confront the CEO directly, adapt her approach, or remain silent – raises critical questions: Is her struggle rooted in the inherent limitations of non-executive power, related to the entrenched culture of a family business or is there an element of unconscious gender bias? Does her experience as a minority on the board shape how her contributions are received, or is the resistance she faces more about her methods? Ultimately, the case challenges readers to consider what it truly means to lead from the boardroom, how to navigate complex interpersonal and organizational dynamics, and how gender and role expectations intersect to shape the effectiveness and credibility of board members.